Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | RGNX REGENXBIO Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $8.68 +1.8% | $16.48 +2.3% |
| StockIQ Score | 43D Weak Risk: High | 35F Weak Risk: High |
| Technical | 29F | 13F |
| Fundamental | 30F | 35F |
| Growth | 76B+ | 50C- |
| Fair Value | 38F | 38F |
| News | 68B- | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
REGENXBIO (RGNX) outperforms Ascentage Pharma (AAPG) in growth and technical analysis, with scores of 76 and 29 versus 50 and 13. Both share the same valuation score of 38 but differ in fundamentals, where RGNX has a slightly higher 30 compared to AAPG’s 35. Investor scores favor AAPG at 35 over RGNX’s 43, though both carry a "WEAK" rating.
